Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,020.00    -110.00 (-1.54%)
Bid:
7,010.00
Ask:
7,020.00
Spread: 10.00 (0.143%)
Market Cap: £9.41b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Trading Statement

17 Mar 2009 07:00

RNS Number : 9511O
Diploma PLC
17 March 2009
 



 

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AXTELEPHONE: +44 (0)20 7549 5700FACSIMILE: +44 (0)20 7549 5715

FOR IMMEDIATE RELEASE

17 March 2009

DIPLOMA PLC

TRADING UPDATE

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing a trading update, ahead of going into close period at 31 March 2009.

The Group's performance during the first half of the year has been impacted by a weakening in the general trading environment across all sectors and particularly in the Seals businesses in North America. At the same time, the continued weakness of UK sterling, relative to all other major currencies, has had a strong positive impact on the Group's results from translation of the results of the overseas businesses.

Against this background, the Group expects reported revenue for the six months ended 31 March 2009 to be a little ahead of the comparable period last year and, on a constant currency basis, down approximately 8-10%.

Operating profits have benefited from currency translation, as well as from the initial contribution of RT Dygert, acquired in January 2009. On a transaction basis, however, currency effects have had a negative effect on gross margins, particularly in the UK and Canadian businesses. Combined with pressures from the generally weaker trading conditions, reported operating profits are likely to be 5-7% below the comparable period last year.

In Life Sciences, the Canadian businesses have continued to make progress in markets where overall funding remains steady, but increased focus is being placed by customers on cost efficiency. The European businesses have experienced some reduction in revenues and have responded by reducing their cost base.

In Seals, the weaker trading conditions seen in the broader US industrial markets towards the end of 2008 have continued and similar effects are now being seen in the European and other international markets. While the Aftermarket businesses have shown some resilience, there has been a more marked slowdown in those businesses supplying to industrial OEMs and construction equipment dealers. Cost reduction programmes have been, and continue to be, implemented across the Seals businesses, but these inevitably lag the revenue reduction and will not fully offset the negative impact from operational leverage.

The Controls businesses have mostly proved to be more buoyant than the general economies in which they operate, due to their focus on technically driven markets. However, some softening in UK revenues has been seen in recent months, particularly in those businesses more exposed to manufacturing markets. Similarly, weaker trading activity is now being experienced in Germany, particularly with those customers who are dependent on export markets. Again cost reduction programmes are being implemented to help mitigate the impact from reducing revenues.

The Group's businesses have responded well in taking action to reduce working capital in response to the reduction in revenues and the Group continues to maintain a strong financial position. After the payment in January 2009 of both the final dividend of 5.0p (£5.6m) and the initial consideration of US$14.4m (£9.5m) for RT/Dygert, the Group will have positive net cash funds at 31 March 2009. Strong operating cash flow is expected in the second half of the year and the Group also maintains committed bank facilities of £20.0m. The ungeared balance sheet and strong cash flow provides a secure platform to support the continued development of the Group.

The Directors will provide an update on trading prospects for the year on Monday, 11 May 2009, as part of their announcement of the Group's results for the six months ended 31 March 2009. 

For further enquiries please contact:

Bruce Thompson, Chief Executive Officer

020 7549 5700

Nigel Lingwood, Group Finance Director

020 7549 5705

Simon Bloomfield, Bankside Consultants

020 7367 8861

NOTE TO EDITORS:

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

Diploma achieves stable growth and attractive margins from its focus on supplying specialised technical products to markets which value high levels of customer service, technical support and value adding activities. A high proportion of revenues are generated from essential products and services funded by operating, rather than capital budgets.

The Group employs ca. 1,000 employees and its principal operating businesses are located in the UKGermany, US and Canada.

In the last five years ended 30 September 2008, the Group has grown adjusted earnings per share at an average of ca. 21% p.a. through a combination of organic growth and acquisitions. The current market capitalisation is ca. £110m.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGUUQCWUPBGMQ
Date   Source Headline
30th May 20237:00 amRNSAppointment of Non-Executive Director
22nd May 20233:30 pmRNSHolding(s) in Company
15th May 20237:00 amRNSHalf-year Report
3rd Apr 20237:00 amRNSTotal Voting Rights
27th Mar 202310:34 amRNSHolding(s) in Company
24th Mar 20234:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20232:34 pmRNSHolding(s) in Company
22nd Mar 20237:00 amRNSIssue of Shares and Total Voting Rights
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
20th Mar 20239:14 amRNSHolding(s) in Company
17th Mar 20236:00 pmRNSDiploma
17th Mar 20237:00 amRNSResult of Placing
16th Mar 20234:47 pmRNSRetail Offer
16th Mar 20234:46 pmRNSProposed Placing
16th Mar 20234:45 pmRNSAcquisition and M&A Pipeline Update
20th Feb 20239:35 amRNSHolding(s) in Company
9th Feb 20238:27 amRNSHolding(s) in Company
30th Jan 20232:53 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSDirector/PDMR Grant of LTIP Award
18th Jan 202311:13 amRNSResult of AGM
18th Jan 20237:00 amRNSTrading Statement
12th Dec 20227:00 amRNSAnnual Financial Report & Notice of AGM
9th Dec 202210:33 amRNSHolding(s) in Company - Replacement
8th Dec 20229:41 amRNSHolding(s) in Company
1st Dec 20227:00 amRNSTotal Voting Rights
29th Nov 20227:00 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSDirector/PDMR Shareholding
21st Nov 20228:28 amRNSHolding(s) in Company
21st Nov 20227:00 amRNSFinal Results
17th Nov 20227:00 amRNSISSUE OF SHARES AND TOTAL VOTING RIGHTS
12th Oct 20222:06 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
8th Sep 20227:30 amRNSDirectorate Change
31st Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirectorate Change
21st Jul 20227:00 amRNSTrading Statement
20th May 20223:19 pmRNSHolding(s) in Company
16th May 20227:00 amRNSHalf-year Report
12th Apr 20227:00 amRNSTrading Statement
8th Mar 20229:36 amRNSHolding(s) in Company
19th Jan 20224:00 pmRNSResult of AGM
19th Jan 20227:00 amRNSTrading Statement
10th Jan 20227:00 amRNSAGM arrangements in light of COVID-19
21st Dec 20217:00 amRNSDirector/PDMR Shareholding
7th Dec 20217:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20217:00 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSDirector/PDMR Shareholding
22nd Nov 20217:06 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.